Merganser Biotech
Latest round
- Series A
Last raised
- Feb 2015
Total raised
- $56M
Investors
- 5
About Merganser Biotech
Founded in 2011, Merganser Biotech, Inc. develops peptidyl therapeutics products and new treatments for diseases involving an overload in iron.
Who invested in Merganser Biotech
5 investors across 3 rounds
See all investors in Merganser Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Merganser Biotech
Who invested in Merganser Biotech?
Merganser Biotech has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Merganser Biotech raised?
Merganser Biotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Merganser Biotech last raise money?
Merganser Biotech's most recent round on record is a Series A, in Feb 2015.
What does Merganser Biotech do?
Founded in 2011, Merganser Biotech, Inc.
Where is Merganser Biotech headquartered?
Merganser Biotech is headquartered in US.
Which VCs invest in companies like Merganser Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Merganser Biotech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Merganser Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.